Related Experiment Video
Updated: Jul 10, 2026

11:10
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures
David P Simmons1, Victor A Streltsov, Olan Dolezal
1CSIRO Division of Molecular and Health Technologies, Parkville, Victoria 3052, Australia.
Proteins
|October 13, 2007
Summary
Researchers developed novel mimotopes using single domain IgNAR antibodies. These mimotopes mimic antigen epitopes, showing higher affinity and offering a powerful tool for molecular library selection.
Area of Science:
- Immunology
- Structural Biology
- Biotechnology
Background:
- Mimotopes mimic antigen epitopes, recognized by antibodies with high affinity.
- Peptides and anti-idiotypic antibodies are known mimotope classes.
- Single domain IgNAR antibodies possess long CDR3 loops, suitable for mimotope development.
Purpose of the Study:
- To develop and characterize novel mimotopes using single domain IgNAR antibodies.
- To investigate the binding affinity and structural basis of IgNAR-derived mimotopes.
- To explore the potential of IgNAR variable domains (V(NAR)s) as constrained peptide libraries.
Main Methods:
- Screening an in vitro phage-display library of IgNAR variable domains against a target antibody (MAb5G8).
- Characterizing four selected V(NAR) mimotopes for binding specificity and affinity using competition studies.
- Conducting crystallographic studies of V(NAR) proteins to determine structural features of mimotope presentation.
Main Results:
- Four V(NAR) mimotopes were identified, binding specifically to the MAb5G8 antibody's paratope.
- V(NAR) mimotopes exhibited enhanced binding affinities (3-46 nM) compared to the parental antigen (175 nM).
- Crystallography revealed SYP motifs on CDR3 loops, stabilized by various interactions, positioned for antibody contact.
Conclusions:
- Single domain IgNAR antibodies can generate high-affinity mimotopes targeting specific epitopes.
- The structural features of IgNAR CDR loops, including stabilization, contribute to enhanced binding.
- Phage-display selection from constrained IgNAR libraries offers a powerful method for discovering novel mimotopes with potentially superior topologies.
Related Concept Videos
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

